Patents by Inventor Thiruvengadam Arumugam

Thiruvengadam Arumugam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Blocking monoclonal antibodies to AGR2 and its receptor C4.4A
    Patent number: 10428159
    Abstract: Provided herein are monoclonal antibodies that recognize, bind to, and block interactions of other molecules with AGR2 and C4.4A. Also provided herein are methods of using anti-AGR2 and anti-C4.4A antibodies to treat cancer.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: October 1, 2019
    Assignee: Board of Regents, The University of Texas System
    Inventors: Craig D. Logsdon, Vijaya Ramachandran, Thiruvengadam Arumugam
  • BLOCKING MONOCLONAL ANTIBODIES TO AGR2 AND ITS RECEPTOR C4.4A
    Publication number: 20170283509
    Abstract: Provided herein are monoclonal antibodies that recognize, bind to, and block interactions of other molecules with AGR2 and C4.4A. Also provided herein are methods of using said antibodies to treat cancer.
    Type: Application
    Filed: September 8, 2015
    Publication date: October 5, 2017
    Applicant: Board of Regents, The University of Texas System
    Inventors: Craig D. LOGSDSON, Vijaya RAMACHANDRAN, Thiruvengadam ARUMUGAM
  • ANTAGONISTS OF THE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE)
    Publication number: 20100249038
    Abstract: Novel peptides are useful as antagonists of RAGE and may be used to treat cancer, inflammation, diabetes and arthritis through the administration of a therapeutically effective amount of the peptide to a subject in need thereof.
    Type: Application
    Filed: June 12, 2008
    Publication date: September 30, 2010
    Inventors: Craig D. Logsdon, Thiruvengadam Arumugam